Biophytis SA (BPTS)

Business: Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases.

IPO Date: 10-Feb-2021

Chairman & CEO: Mr. Stanislas Veillet Ph.D.

Chief Financial Officer: Mr. Philippe J. Rousseau

Listing: NASDAQ: BPTS

Country: France

Headquarters: Paris,

Website: https://www.biophytis.com

Market cap: $17.97 Mln

Revenue (TTM): €0.00 Mln

Earnings (TTM): €-31.25 Mln

Cash: €25.16 Mln

Total Debt: €15.38 Mln

Insider's Holding: 0.00%

Liquidity: Low

52 Week range: $0.94 - 10.69

Shares outstanding: 14,754,100

9 Years Aggregate:

• CFO: €-81.02 Mln
• EBITDA: €-94.63 Mln
• Net Profit: €-103.96 Mln